Barclays’s Akcea Therapeutics, Inc. Common Stock AKCA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-38,334
| Closed | -$696K | – | 3809 |
|
|
2020
Q3 | $696K | Buy |
38,334
+4,388
| +13% | +$79.7K | ﹤0.01% | 2130 |
|
|
2020
Q2 | $465K | Buy |
33,946
+15,952
| +89% | +$219K | ﹤0.01% | 2357 |
|
|
2020
Q1 | $257K | Sell |
17,994
-492
| -3% | -$7.03K | ﹤0.01% | 2428 |
|
|
2019
Q4 | $312K | Buy |
18,486
+2,895
| +19% | +$48.9K | ﹤0.01% | 2952 |
|
|
2019
Q3 | $240K | Buy |
15,591
+7,568
| +94% | +$116K | ﹤0.01% | 2984 |
|
|
2019
Q2 | $188K | Sell |
8,023
-2,671
| -25% | -$62.6K | ﹤0.01% | 3237 |
|
|
2019
Q1 | $302K | Buy |
10,694
+4,294
| +67% | +$121K | ﹤0.01% | 2851 |
|
|
2018
Q4 | $193K | Sell |
6,400
-6,481
| -50% | -$195K | ﹤0.01% | 2729 |
|
|
2018
Q3 | $451K | Sell |
12,881
-1,484
| -10% | -$52K | ﹤0.01% | 2686 |
|
|
2018
Q2 | $340K | Buy |
14,365
+3,053
| +27% | +$72.3K | ﹤0.01% | 2483 |
|
|
2018
Q1 | $290K | Buy |
11,312
+8,934
| +376% | +$229K | ﹤0.01% | 2625 |
|
|
2017
Q4 | $41K | Buy |
2,378
+2,030
| +583% | +$35K | ﹤0.01% | 3424 |
|
|
2017
Q3 | $10K | Buy |
+348
| New | +$10K | ﹤0.01% | 3450 |
|